NEW YORK (GenomeWeb News) – Swiss molecular diagnostics firm Diagnoplex today said that it has closed a Series A financing round, raising CHF 10 million ($8.3 million) in funding.
 
Diagnoplex said that it would use proceeds from the financing to further develop its Colox non-invasive test for early detection of colon cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.